Retinoic Acid Receptor and Tumor Formation in Mice
Author Information
Author(s): Tara S. Kupumbati, Giorgio Cattoretti, Christine Marzan, Eduardo F. Farias, Reshma Taneja, Rafael Mira-y-Lopez
Primary Institution: Mount Sinai School of Medicine
Hypothesis
Chronic physiological RAR activation by endogenous retinoids may be anti-tumorigenic.
Conclusion
The study suggests that physiological RAR activity may suppress tumor growth in B lymphocytes and mammary epithelial cells.
Supporting Evidence
- Transgenic mice developed B cell lymphomas at high penetrance.
- Mammary tumors were not observed in the transgenic mice during the study period.
- A metastatic mammary adenocarcinoma developed in one of four transplanted glands.
Takeaway
Scientists created special mice to see if a certain protein could stop tumors from growing, and they found that when the protein didn't work, tumors formed.
Methodology
Transgenic mice were created to express a dominant negative RARα, and tumor development was monitored over time.
Limitations
The study's findings are preliminary and require further validation in larger studies.
Participant Demographics
Transgenic mice were used in the study.
Statistical Information
P-Value
0.035
Statistical Significance
p = 0.035
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website